Discontinued — last reported Q4 '25
Health & Civil — Revenue
Leidos Holdings Health & Civil — Revenue decreased by 7.4% to $1.21B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.3%, from $1.33B to $1.21B. Over 3 years (FY 2022 to FY 2025), Health & Civil — Revenue shows an upward trend with a 8.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful contract wins and expansion in the health and civil government markets, while a decrease may signal contract expirations or reduced demand.
Detailed definition
Represents the total gross income generated by the Health and Civil business segment through the delivery of technology,...
Peer comparison
Standard revenue reporting for government services segments across defense and technology peers.
ldos_segment_health_civil_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $986.25M | $986.25M | $986.25M | $986.25M | $1.01B | $1.03B | $1.06B | $1.14B | $1.20B | $1.26B | $1.23B | $1.33B | $1.29B | $1.27B | $1.30B | $1.21B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.2% | +2.6% | +2.0% | +8.2% | +5.1% | +5.3% | -3.0% | +8.4% | -2.8% | -1.5% | +2.3% | -7.4% |
| YoY Change | — | — | — | — | +2.2% | +4.8% | +7.0% | +15.7% | +18.9% | +22.1% | +16.1% | +16.4% | +7.7% | +0.7% | +6.2% | -9.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Leidos Holdings's health & civil — revenue?
- Leidos Holdings (LDOS) reported health & civil — revenue of $1.21B in Q4 2025.
- How has Leidos Holdings's health & civil — revenue changed year-over-year?
- Leidos Holdings's health & civil — revenue decreased by 9.3% year-over-year, from $1.33B to $1.21B.
- What is the long-term trend for Leidos Holdings's health & civil — revenue?
- Over 3 years (2022 to 2025), Leidos Holdings's health & civil — revenue has grown at a 8.7% compound annual growth rate (CAGR), from $3.95B to $5.07B.
- What does health & civil — revenue mean?
- The total sales revenue generated by the Health and Civil business segment.